Parkside Financial Bank & Trust Dexcom Inc Transaction History

Parkside Financial Bank & Trust

$742 Million
Q4 2024

A detailed history of Parkside Financial Bank & Trust transactions in Dexcom Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 2,009 shares of DXCM stock, worth $143,964. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,009

Previous 1,684 19.3%

Holding current value

$143,964

Previous $112,000 39.29%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$65.68 - $81.01 $21,346 - $26,328	325 Added 19.3%	2,009 $156,000
Q3 2024 Nov 07, 2024	SELL	$64.0 - $116.06 $39,808 - $72,189	-622 Reduced 26.97%	1,684 $112,000
Q2 2024 Aug 05, 2024	BUY	$110.31 - $140.45 $1,323 - $1,685	12 Added 0.52%	2,306 $261,000
Q1 2024 May 01, 2024	BUY	$114.22 - $140.1 $23,757 - $29,140	208 Added 9.97%	2,294 $318,000
Q4 2023 Feb 01, 2024	BUY	$75.49 - $124.16 $16,456 - $27,066	218 Added 11.67%	2,086 $258,000
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $11,584 - $13,490	103 Added 5.84%	1,868 $240,000
Q1 2023 May 04, 2023	BUY	$104.0 - $122.92 $728 - $860	7 Added 0.4%	1,765 $205,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $24,304 - $35,083	286 Added 19.43%	1,758 $199,000
Q3 2022 Nov 01, 2022	SELL	$76.35 - $94.18 $5,268 - $6,498	-69 Reduced 4.48%	1,472 $119,000
Q2 2022 Jul 13, 2022	BUY	$67.99 - $132.89 $94,914 - $185,514	1,396 Added 962.76%	1,541 $114,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $376 - $520	4 Added 2.84%	145 $74,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $3,896 - $4,884	30 Added 27.03%	141 $75,000
Q3 2021 Oct 29, 2021	BUY	$106.71 - $143.18 $4,908 - $6,586	46 Added 70.77%	111 $61,000
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $3,077 - $4,101	38 Added 140.74%	65 $28,000
Q1 2021 May 10, 2021	BUY	$84.79 - $104.74 $763 - $942	9 Added 50.0%	27 $10,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $6,474 - $8,673	-83 Reduced 82.18%	18 $6,000
Q3 2020 Nov 06, 2020	BUY	$95.51 - $112.95 $95 - $112	1 Added 1.0%	101 $42,000
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $2,381 - $4,002	-38 Reduced 27.54%	100 $41,000
Q1 2020 May 05, 2020	SELL	$47.79 - $75.63 $2,628 - $4,159	-55 Reduced 28.5%	138 $37,000
Q4 2019 Jan 30, 2020	BUY	$36.62 - $57.29 $695 - $1,088	19 Added 10.92%	193 $42,000
Q3 2019 Nov 05, 2019	BUY	$35.53 - $43.8 $568 - $700	16 Added 10.13%	174 $26,000
Q1 2019 May 01, 2019	SELL	$28.07 - $38.18 $449 - $610	-16 Reduced 9.2%	158 $19,000
Q4 2018 Jan 31, 2019	BUY	$26.99 - $37.37 $431 - $597	16 Added 10.13%	174 $21,000
Q2 2018 Aug 03, 2018	BUY	$17.54 - $25.22 $1,613 - $2,320	92 Added 139.39%	158 $15,000
Q1 2018 May 02, 2018	BUY	$13.06 - $18.54 $861 - $1,223	66 New	66 $5,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

353M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.7B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Dexcom Inc Transaction History